Cargando...
A Review of mTOR Pathway Inhibitors in Gynecologic Cancer
The treatment of advanced gynecologic cancers remains palliative in most of cases. Although systemic treatment has entered into the era of targeted drugs the antitumor efficacies of current therapies are still limited. In this context there is a great need for more active treatment and rationally de...
Gardado en:
| Publicado en: | Oxid Med Cell Longev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi Publishing Corporation
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5327776/ https://ncbi.nlm.nih.gov/pubmed/28286604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4809751 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|